Clinical Trials

Phase 1/2 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06084884 2026-03-09

ATHENA

94 enrolled

Phase 3 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03847428 2026-03-06

EMERALD-2

908 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

120 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT05438420 2026-02-24

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

120 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Stomach Neoplasms

NCT05883644 2026-02-18

SIERRA

Phase 3 Active not recruiting

111 enrolled

Liver Neoplasms

NCT04736121 2026-02-03

DOORwaY90

100 enrolled

Liver Neoplasms

NCT07362264 2026-01-23

A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

50 enrolled

Liver Neoplasms

NCT04573881 2026-01-12

#HOPE4LIVER

24 enrolled 12 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04597710 2025-12-01

Precision1

Active not recruiting

200 enrolled

Phase 3 Active not recruiting

Liver Neoplasms

NCT03383458 2025-11-21

CheckMate 9DX

545 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04572633 2025-11-19

#HOPE4LIVER US

47 enrolled 15 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05064553 2025-10-15

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Active not recruiting

2,990 enrolled

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms

NCT03993873 2025-10-01

SHIELD-1

95 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT03132792 2025-08-15

AFPᶜ³³²T in Advanced HCC

45 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Liver Neoplasms, Neoplasm Metastasis

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

1,000 enrolled

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT03552718 2024-07-17

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.